Described herein are pharmaceutical packaging methods which reduce oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive medicine, these kinds of devices which include a syringe with the oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with very lower permeability